Cargando…

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab

In COVID-19, acute respiratory distress syndrome (ARDS) and thrombotic events are frequent, life-threatening complications. Autopsies commonly show arterial thrombosis and severe endothelial damage. Endothelial damage, which can play an early and central pathogenic role in ARDS and thrombosis, activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rambaldi, Alessandro, Gritti, Giuseppe, Micò, Maria Caterina, Frigeni, Marco, Borleri, Gianmaria, Salvi, Anna, Landi, Francesco, Pavoni, Chiara, Sonzogni, Aurelio, Gianatti, Andrea, Binda, Francesca, Fagiuoli, Stefano, Di Marco, Fabiano, Lorini, Luca, Remuzzi, Giuseppe, Whitaker, Steve, Demopulos, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier GmbH. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415163/ https://www.ncbi.nlm.nih.gov/pubmed/32943233 http://dx.doi.org/10.1016/j.imbio.2020.152001

Ejemplares similares

Narsoplimab for severe transplant-associated thrombotic microangiopathy
por: Pandrowala, Ambreen, et al.
Publicado: (2023)

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy
por: Khaled, Samer K., et al.
Publicado: (2022)

Bergamo and Covid-19: How the Dark Can Turn to Light
por: Perico, Norberto, et al.
Publicado: (2021)

Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
por: Gritti, Giuseppe, et al.
Publicado: (2021)

Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
por: Gritti, Giuseppe, et al.
Publicado: (2021)

Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure
por: Damiani, Marianna, et al.
Publicado: (2021)

Adaptations and Lessons in the Province of Bergamo
por: Fagiuoli, Stefano, et al.
Publicado: (2020)

Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?
por: Gritti, Giuseppe, et al.
Publicado: (2017)

MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab
por: Elhadad, S., et al.
Publicado: (2020)

Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia
por: Lussana, Federico, et al.
Publicado: (2019)

Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders
por: Dudler, Thomas, et al.
Publicado: (2023)

Primary Treatment Response Rather than Front Line Stem Cell Transplantation Is Crucial for Long Term Outcome of Peripheral T-Cell Lymphomas
por: Gritti, Giuseppe, et al.
Publicado: (2015)

Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
por: Gritti, Giuseppe, et al.
Publicado: (2018)

Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
por: Lafayette, Richard A., et al.
Publicado: (2020)

Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell–Redirected Bispecific Antibodies
por: Lussana, Federico, et al.
Publicado: (2021)

RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells
por: Gianni, Maurizio, et al.
Publicado: (2016)

P1180: BURKITT INTERNATIONAL PROGNOSTIC INDEX EVALUATED IN PATIENTS TREATED WITH R-GMALL PROTOCOL
por: Rizzuto, Giuliana, et al.
Publicado: (2023)

Characterization of compliance phenotypes in COVID-19 acute respiratory distress syndrome
por: Zacchetti, Lucia, et al.
Publicado: (2022)

Megakaryoblasts in a newborn with Down syndrome
por: Buoro, Sabrina, et al.
Publicado: (2018)

Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy
por: Minenkova, Olga, et al.
Publicado: (2022)

Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination
por: Taurino, Daniela, et al.
Publicado: (2021)

Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID‐19
por: Lynch, Nicholas J., et al.
Publicado: (2022)

Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study
por: Raimondi, Federico, et al.
Publicado: (2021)

High inter‐follicular spatial co‐localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma
por: Hagos, Yeman B., et al.
Publicado: (2022)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation
por: Duca, Andrea, et al.
Publicado: (2020)

Occupational health and safety of road haulage company employees
por: Riva, Matteo Marco, et al.
Publicado: (2018)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Microangiopathy in Rheumatic Diseases
por: Lambova, Sevdalina Nikolova
Publicado: (2023)

COVID-19 and Italy: what next?
por: Remuzzi, Andrea, et al.
Publicado: (2020)

Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan Criteria
por: Magro, Bianca, et al.
Publicado: (2021)

Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19
por: Morotti, Denise, et al.
Publicado: (2021)

Laparostomy versus laparotomy in severe abdominal infection: microbiological assessment
por: Pavoni, V, et al.
Publicado: (2005)

Burn variables and intensive care mortality in severe burn patients
por: Gianesello, L, et al.
Publicado: (2004)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
por: Mazzierli, Tommaso, et al.
Publicado: (2023)

Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19
por: Matoori, Simon, et al.
Publicado: (2021)

Regenerative Therapies for Diabetic Microangiopathy
por: Bassi, Roberto, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hjajvm6lqm508n2del9j6itgh7